Welcome to LookChem.com Sign In|Join Free
  • or
(1-benzothien-3-yl)(1-hydroxycyclohexyl)acetic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

850615-89-3

Post Buying Request

850615-89-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

850615-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 850615-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,6,1 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 850615-89:
(8*8)+(7*5)+(6*0)+(5*6)+(4*1)+(3*5)+(2*8)+(1*9)=173
173 % 10 = 3
So 850615-89-3 is a valid CAS Registry Number.

850615-89-3Relevant academic research and scientific papers

Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors

Sabatucci, Joseph P.,Mahaney, Paige E.,Leiter, Jennifer,Johnston, Grace,Burroughs, Kevin,Cosmi, Scott,Zhang, Yingru,Ho, Douglas,Deecher, Darlene C.,Trybulski, Eugene

scheme or table, p. 2809 - 2812 (2010/08/21)

A series of heterocyclic cycloalkanol ethylamines have been prepared to expand our norepinephrine reuptake inhibitor (NRI) program. Synthesis of a variety of heterocycles identified (+)-S-21, a potent NRI efficacious in an animal model for thermoregulatory dysfunction.

1- 2’ (1, 4’-BIPERIDIN-1’-YL)-1- (PHENYL) -ETHYL CYCLOHEXANOL DERIVATIVES AS MONOAMINE REUPTAKE MODULATORS FOR THE TREATMENT OF VISOMOTOR SYMPTOMS

-

Page/Page column 56, (2008/06/13)

The present invention is directed to substituted N-heterocycle derivatives of formula (I), compositions containing these derivatives, and their use in the manufacture of a medicament for the prevention and treatment of conditions ameliorated by monoamine

ARYLALKYL- AND CYCLOALKYLALKYL-PIPERAZINE DERIVATIVES AND METHODS OF THEIR USE

-

Page/Page column 56, (2008/06/13)

The present invention is directed to arylalkyl- and cycloalkylalkyl-piperazine derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, int

SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE

-

Page/Page column 59, (2008/06/13)

The present invention is directed to substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia,vas

Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use

-

Page/Page column 15, (2010/02/14)

The present invention is directed to secondary amino- and cycloamino-cycloalkanol derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 850615-89-3